Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Immunoprecise Antibodies Ltd
IPA
Healthcare
Biotechnology
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem...
Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:IPA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(2377)
•••
dart321
X
View Profile
View Bullboard History
Comment by
dart321
on Nov 01, 2024 10:01pm
RE:RE:RE:Why haven't you read the Oct.2&10 posts here?
Hey wallyworld what ever happened to the big pumps. You know the ones where you said it was going to 30 or 40 bucks, Oh right the path has been there all along, did everyone get lost on the path? Did
...more
(2377)
•••
dart321
X
View Profile
View Bullboard History
Comment by
dart321
on Oct 30, 2024 1:02pm
RE:RE:RE:Why haven't you read the Oct.2&10 posts here?
wallyworld, is it pink sheet time? It's like rats running away from a dumpster fire.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 28, 2024 7:31am
New Press Release - ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology
Rabbit B Cell Select® Platform Yields Novel Antibodies for Studying Age-Related Mitochondrial Dysfunction ImmunoPrecise Antibodies Ltd. ("IPA" or the "Company") (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, announces its significant contribution to a groundbreaking...
read article.
(22)
•••
wallpaper2
X
View Profile
View Bullboard History
Comment by
wallpaper2
on Oct 27, 2024 7:28am
RE:RE:Why haven't you read the Oct.2&10 posts here?
The path has been there all along, if you had looked with an open mind.
(33)
•••
dwitzany
X
View Profile
View Bullboard History
Comment by
dwitzany
on Oct 25, 2024 12:49pm
RE:Why haven't you read the Oct.2&10 posts here?
I read the posts, but I also looked at the 10-year chart..., I got out years ago; this company has always been a tech story, and AI is the latest flavor of icing. What it HAS done over
...more
(22)
•••
wallpaper2
X
View Profile
View Bullboard History
Post by
wallpaper2
on Oct 24, 2024 3:28am
Why haven't you read the Oct.2&10 posts here?
Nobody appears to have read these 2 previous posts. Are you not into AI and Drug Discovery?
(22)
•••
wallpaper2
X
View Profile
View Bullboard History
Post by
wallpaper2
on Oct 21, 2024 1:37pm
IPA is hugely oversold!
And ready for a signicant move. Major news due this week. AI..DRUG DISCOVERY..THERAPEUTICS..CRO revenue.. Collaborations..Partnerships. Give it a read!!!
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Oct 10, 2024 11:18am
ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry
JUST IN: $IPA ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein DesignUniversity of Washington@s Baker Lab and Google DeepMind Redefine Protein Science
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 10, 2024 8:11am
New Press Release - ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design
University of Washington’s Baker Lab and Google DeepMind Redefine Protein Science, Paving the Way for AI-Driven Biotherapeutics ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today celebrates the recent Nobel...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 02, 2024 8:08am
New Press Release - ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus
Talem Therapeutics' Antibody Asset to be Evaluated for Bispecific Development Against Solid Tumors ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, and Biotheus Inc. (Biotheus), a clinical-stage biotech company...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 26, 2024 9:01am
New Press Release - ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments
Rabbit B Cell Select® Drives Clinical Breakthroughs in Cancer Treatment ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today proudly announces...
read article.
(22)
•••
wallpaper2
X
View Profile
View Bullboard History
Post by
wallpaper2
on Sep 19, 2024 10:29am
Something happening.
Couple of days of over 400,000 shs trading is telling us something. We are over due for significant news releases!
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 16, 2024 9:09am
New Press Release - ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025
Achieves $5.3 Million First Quarter Revenue, Reaches Milestone Developing Antibodies End-to-End Using LENSai IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, today reported financial results...
read article.
(3)
•••
AxeCap
X
View Profile
View Bullboard History
Comment by
AxeCap
on Sep 10, 2024 7:04pm
RE:RE:RE:Well that didn't last long lol
1.02 to .81 in two days is what then? Now at .66 only a couple weeks later. It was pumped to avoid minimum price compliance issues which is happening. Maybe it will have better luck on
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Do you want to stay ahead of the markets? See how DealRoom can help.